| Date Filed | Type | Description |
| 07/05/2023 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 4,575 options to buy
@ $0.3552, valued at
$1.6k
|
|
| 04/04/2023 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 1,167 options to buy
@ $1.75, valued at
$2k
|
|
| 01/03/2023 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 410 options to buy
@ $5.0401, valued at
$2.1k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 4,338 options to buy
@ $0.5, valued at
$2.2k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
3
| Almenoff June Sherie (Director) has filed a Form 3 on TENAX THERAPEUTICS, INC. |
| 04/04/2022 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 2,985 options to buy
@ $0.7247, valued at
$2.2k
|
|
| 01/04/2022 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 737 options to buy
@ $1.7, valued at
$1.3k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $2.28, valued at
$182.4k
|
|
| 11/12/2021 |
3
| Almenoff June Sherie (Director) has filed a Form 3 on Avalo Therapeutics, Inc. |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Bought 1,475 shares
@ $3.39, valued at
$5k
|
|
| 08/28/2018 |
4
| Almenoff June Sherie (COO and Chief Medical Officer) has filed a Form 4 on INNOVATE BIOPHARMACEUTICALS, INC.|
Txns:
| Bought 100 shares
@ $4.85, valued at
$485
Bought 400 shares
@ $4.99, valued at
$2k
Bought 47 shares
@ $4.9, valued at
$230.3
Bought 253 shares
@ $4.96, valued at
$1.3k
Bought 100 shares
@ $4.94, valued at
$494
Bought 500 shares
@ $4.85, valued at
$2.4k
|
|
| 03/20/2018 |
4/A
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Bought 5,700 shares
@ $3.5, valued at
$20k
|
|
| 03/19/2018 |
3
| Almenoff June Sherie (COO and Chief Medical Officer) has filed a Form 3 on INNOVATE BIOPHARMACEUTICALS, INC. |
| 03/16/2018 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Granted 5,700 shares
@ $3.5, valued at
$20k
|
|
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/11/2016 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Ohr Pharmaceutical Inc|
Txns:
| Granted 60,000 options to buy
@ $5.14, valued at
$308.4k
|
|
| 03/12/2015 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Ohr Pharmaceutical Inc|
Txns:
| Granted 84,000 options
@ $10.14, valued at
$851.8k
Granted 84,000 options
@ $10.14, valued at
$851.8k
|
|
| 02/10/2015 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Ohr Pharmaceutical Inc|
Txns:
| Bought 6,000 shares
@ $6.75, valued at
$40.5k
|
|
| 09/04/2014 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Ohr Pharmaceutical Inc|
Txns:
| Bought 1,000 shares
@ $8.12, valued at
$8.1k
Bought 1,200 shares
@ $8.05, valued at
$9.7k
|
|
| 07/07/2014 |
4
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 24,600 shares
@ $0
Disposed/sold 83,000 options to buy
@ $9.11, valued at
$756.1k
Disposed/sold 27,000 options to buy
@ $15, valued at
$405k
Disposed/sold 21,970 options to buy
@ $13.16, valued at
$289.1k
Disposed/sold 6,912 options to buy
@ $17.8, valued at
$123k
|
|
| 06/30/2014 |
4
| Almenoff June Sherie (Director) has filed a Form 4 on Ohr Pharmaceutical Inc|
Txns:
| Bought 3,200 shares
@ $8.34, valued at
$26.7k
|
|
| 04/09/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2014 |
4
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 93,395 shares
@ $114.6, valued at
$10.7M
Sold 21,718 shares
@ $118.25, valued at
$2.6M
Exercised 27,000 options to buy
@ $9.11, valued at
$246k
Exercised 21,718 options to buy
@ $9.11, valued at
$197.9k
Exercised 19,000 options to buy
@ $15, valued at
$285k
Exercised 43,939 options to buy
@ $13.16, valued at
$578.2k
Exercised 3,456 options to buy
@ $17.8, valued at
$61.5k
|
|
| 06/24/2013 |
3
| Almenoff June Sherie (Director) has filed a Form 3 on Ohr Pharmaceutical Inc |
| 06/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/16/2012 |
4
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Bought 50 shares
@ $18.55, valued at
$927.5
Bought 950 shares
@ $18.68, valued at
$17.7k
|
|
|